Treatment of micropapillary carcinoma of the thyroid: where do we draw the line?
Two patients with papillary thyroid cancer were seen in consultation after they had been treated in other medical centers. Their cancers measured 1 and 1.2 mm, respectively. Both patients were treated by two thyroid operations and (131)I ablation. We believe that, apart from lobectomy, these therapies were not justified. We draw attention to this to provide a topic for debate and to attempt to prevent this happening to other patients.
McDougall
I Ross
IR
Division of Nuclear Medicine and Molecular Imaging Program at Stanford, Department of Radiology, Stanford University Hospital and Clinics, 300 Pasteur Drive, Stanford, CA 94305, USA. rossmcdougall@stanford.edu
Camargo
Carlos A
CA
D000328:Adult; D002291:Carcinoma, Papillary / Q000532:radiotherapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013964:Thyroid Neoplasms / Q000532:radiotherapy* / Q000601:surgery*; D013965:Thyroidectomy / Q000379:methods
D007457:Iodine Radioisotopes